← All drugs
Drug

Levocarnitine Oral

124 flagged reaction(s) · 2,329 total co-reports · max PRR 22.2
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Status Epilepticus 35 22.2 22.4 signal
2 Seizure 288 18.0 19.8 signal
3 Generalised Tonic-clonic Seizure 31 13.6 13.7 signal
4 Epilepsy 56 13.1 13.4 signal
5 Hepatic Encephalopathy 16 12.3 12.3 signal
6 Device Related Infection 26 12.1 12.2 signal
7 Prescribed Underdose 33 11.8 12.0 signal
8 Tachypnoea 22 11.6 11.7 signal
9 Clostridium Difficile Colitis 16 10.8 10.8 signal
10 Gastroenteritis Viral 25 9.9 9.9 signal
11 Metabolic Acidosis 38 8.6 8.7 signal
12 Spinal Pain 14 8.5 8.6 signal
13 Neutrophil Count Increased 12 8.3 8.4 signal
14 Pneumonia Aspiration 27 7.7 7.8 signal
15 Blood Urea Increased 18 7.6 7.7 signal
16 Pulmonary Congestion 14 7.6 7.6 signal
17 Multiple Organ Dysfunction Syndrome 26 6.7 6.7 signal
18 Hypotonia 9 6.4 6.4 signal
19 Obesity 14 6.3 6.3 signal
20 Bacteraemia 10 6.1 6.1 signal
21 Acute Respiratory Distress Syndrome 15 6.1 6.1 signal
22 Retching 18 6.0 6.1 signal
23 Viral Infection 28 6.0 6.1 signal
24 Gastroenteritis 12 5.9 5.9 signal
25 Vitamin D Deficiency 8 5.9 5.9 signal
26 Malnutrition 9 5.8 5.8 signal
27 Cholestasis 15 5.6 5.6 signal
28 Iron Deficiency Anaemia 7 5.4 5.5 signal
29 Myoclonus 9 5.4 5.4 signal
30 Hypophagia 19 5.4 5.4 signal
31 Shock 17 5.3 5.3 signal
32 Lymphocyte Count Decreased 13 5.3 5.3 signal
33 Rebound Effect 8 5.0 5.1 signal
34 Altered State Of Consciousness 15 5.0 5.0 signal
35 Hepatic Failure 21 5.0 5.0 signal
36 Encephalopathy 17 5.0 5.0 signal
37 Product Prescribing Error 16 4.8 4.8 signal
38 Prescribed Overdose 13 4.8 4.8 signal
39 Adrenal Insufficiency 8 4.8 4.8 signal
40 Coagulopathy 11 4.7 4.7 signal
41 Acute Hepatic Failure 9 4.7 4.7 signal
42 Hepatic Cytolysis 8 4.7 4.7 signal
43 Ileus 8 4.6 4.7 signal
44 Secretion Discharge 8 4.6 4.6 signal
45 Product Use Complaint 10 4.6 4.6 signal
46 Blood Bilirubin Increased 17 4.5 4.5 signal
47 Supraventricular Tachycardia 6 4.5 4.5 signal
48 Respiratory Tract Infection 16 4.4 4.4 signal
49 Feeding Disorder 12 4.3 4.3 signal
50 Hypersomnia 17 4.2 4.3 signal
51 Bacterial Infection 11 4.2 4.2 signal
52 Febrile Neutropenia 39 4.2 4.3 signal
53 Hyperbilirubinaemia 6 4.2 4.2 signal
54 Blood Creatine Phosphokinase Increased 17 4.2 4.2 signal
55 Hyperglycaemia 21 4.1 4.2 signal
56 Respiratory Failure 42 4.1 4.2 signal
57 Hepatic Function Abnormal 21 4.0 4.1 signal
58 Cardiogenic Shock 8 4.0 4.0 signal
59 Rhabdomyolysis 23 3.9 4.0 signal
60 Respiratory Distress 15 3.9 3.9 signal
61 Insurance Issue 8 3.8 3.9 signal
62 Skin Infection 6 3.8 3.8 signal
63 Personality Change 5 3.8 3.8 signal
64 Grand Mal Convulsion 5 3.8 3.8 signal
65 Hypocalcaemia 10 3.8 3.8 signal
66 Somnolence 105 3.7 3.8 signal
67 Poor Quality Sleep 11 3.7 3.7 signal
68 Abnormal Behaviour 20 3.6 3.6 signal
69 Respiratory Depression 6 3.5 3.5 signal
70 Influenza 54 3.5 3.5 signal
71 Jaundice 13 3.4 3.5 signal
72 Proteinuria 9 3.4 3.4 signal
73 Dyskinesia 19 3.3 3.4 signal
74 Therapy Partial Responder 7 3.3 3.3 signal
75 Pancreatitis 24 3.2 3.3 signal
76 Femur Fracture 14 3.2 3.2 signal
77 Pancytopenia 25 3.2 3.2 signal
78 Agitation 32 3.1 3.1 signal
79 Hospitalisation 66 3.1 3.1 signal
80 Appendicitis 4 3.1 3.1 no signal
81 Blood Test Abnormal 6 3.1 3.1 signal
82 Underdose 31 3.0 3.1 signal
83 Electrocardiogram Qt Prolonged 15 3.0 3.0 signal
84 International Normalised Ratio Increased 12 3.0 3.0 signal
85 Nervous System Disorder 13 3.0 3.0 signal
86 Therapy Change 4 3.0 3.0 no signal
87 Hyperthyroidism 6 3.0 3.0 signal
88 Affect Lability 4 3.0 3.0 no signal
89 Aggression 20 2.8 2.9 signal
90 Hypothermia 4 2.8 2.8 no signal
91 Initial Insomnia 4 2.8 2.8 no signal
92 Product Dose Omission Issue 110 2.8 2.8 signal
93 Peritonitis 8 2.8 2.8 signal
94 Covid-19 67 2.7 2.7 signal
95 Complication Associated With Device 5 2.7 2.7 no signal
96 Lactic Acidosis 12 2.7 2.7 signal
97 Pharyngitis Streptococcal 4 2.6 2.6 no signal
98 Product Dispensing Error 8 2.6 2.6 signal
99 Drug Level Increased 6 2.6 2.6 signal
100 Irritability 21 2.5 2.5 signal
101 Sedation 9 2.5 2.5 signal
102 Bone Marrow Failure 7 2.4 2.4 signal
103 Multi-organ Failure 6 2.4 2.4 no signal
104 Laboratory Test Abnormal 10 2.4 2.4 signal
105 Intentional Dose Omission 9 2.4 2.4 signal
106 Convulsion 19 2.3 2.3 signal
107 Abortion Induced 3 2.3 2.3 no signal
108 Posterior Reversible Encephalopathy Syndrome 3 2.3 2.3 no signal
109 Thrombotic Microangiopathy 3 2.2 2.2 no signal
110 Eye Irritation 17 2.2 2.2 signal
111 Psychomotor Hyperactivity 5 2.1 2.1 no signal
112 Diabetes Mellitus Inadequate Control 5 2.0 2.0 no signal
113 Hepatocellular Injury 4 2.0 2.0 no signal
114 Application Site Pain 6 1.9 1.9 no signal
115 Anger 9 1.9 1.9 no signal
116 Muscle Spasticity 3 1.7 1.7 no signal
117 Cytomegalovirus Infection 4 1.7 1.7 no signal
118 Overdose 51 1.7 1.7 no signal
119 Diabetic Ketoacidosis 5 1.5 1.5 no signal
120 Device Breakage 8 1.5 1.5 no signal
121 Product Preparation Error 3 1.0 1.0 no signal
122 Tardive Dyskinesia 3 0.8 0.8 no signal
123 Device Leakage 4 0.7 0.7 no signal
124 Drug Dose Omission By Device 7 0.7 0.7 no signal